Your browser doesn't support javascript.
loading
Capacity for the management of kidney failure in the International Society of Nephrology Western Europe region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA).
Pippias, Maria; Alfano, Gaetano; Kelly, Dearbhla M; Soler, Maria Jose; De Chiara, Letizia; Olanrewaju, Timothy O; Arruebo, Silvia; Bello, Aminu K; Caskey, Fergus J; Damster, Sandrine; Donner, Jo-Ann; Jha, Vivekanand; Johnson, David W; Levin, Adeera; Malik, Charu; Nangaku, Masaomi; Okpechi, Ikechi G; Tonelli, Marcello; Ye, Feng; Coppo, Rosanna; Lightstone, Liz.
Afiliación
  • Pippias M; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
  • Alfano G; Renal Unit, North Bristol NHS Trust, Bristol, UK.
  • Kelly DM; Nephrology Dialysis and Transplant Unit, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
  • Soler MJ; Wolfson Centre for the Prevention of Stroke and Dementia, University of Oxford, John Radcliffe Hospital, Oxford, UK.
  • De Chiara L; Department of Intensive Care Medicine, John Radcliffe Hospital, Oxford, UK.
  • Olanrewaju TO; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Research, CSUR National Unit of Expertise for Complex Glomerular Diseases of Spain, Barcelona, Spain.
  • Arruebo S; Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy.
  • Bello AK; Division of Nephrology, Department of Medicine, College of Health Sciences, University of Ilorin, Ilorin, Nigeria.
  • Caskey FJ; Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Damster S; The International Society of Nephrology, Brussels, Belgium.
  • Donner JA; Division of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
  • Jha V; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
  • Johnson DW; The International Society of Nephrology, Brussels, Belgium.
  • Levin A; The International Society of Nephrology, Brussels, Belgium.
  • Malik C; George Institute for Global Health, University of New South Wales (UNSW), New Delhi, India.
  • Nangaku M; School of Public Health, Imperial College, London, UK.
  • Okpechi IG; Manipal Academy of Higher Education, Manipal, India.
  • Tonelli M; Department of Kidney and Transplant Services, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
  • Ye F; Centre for Kidney Disease Research, University of Queensland at Princess Alexandra Hospital, Brisbane, Queensland, Australia.
  • Coppo R; Translational Research Institute, Brisbane, Queensland, Australia.
  • Lightstone L; Australasian Kidney Trials Network at the University of Queensland, Brisbane, Queensland, Australia.
Kidney Int Suppl (2011) ; 13(1): 136-151, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38618502
ABSTRACT
Western Europe boasts advanced health care systems, robust kidney care guidelines, and a well-established health care workforce. Despite this, significant disparities in kidney replacement therapy incidence, prevalence, and transplant access exist. This paper presents the third International Society of Nephrology Global Kidney Health Atlas's findings on kidney care availability, accessibility, affordability, and quality in 22 Western European countries, representing 99% of the region's population. The known chronic kidney disease (CKD) prevalence across Western Europe averages 10.6%, slightly above the global median. Cardiovascular diseases account for a substantial portion of CKD-related deaths. Kidney failure incidence varies. Government health expenditure differs; however, most countries offer government-funded acute kidney injury, dialysis, and kidney transplantation care. Hemodialysis and peritoneal dialysis are universally available, with variations in the number of dialysis centers. Kidney transplantation is available in all countries (except for 3 microstates), with variable transplant center prevalence. Conservative kidney management (CKM) is increasingly accessible. The region's kidney care workforce is substantial, exceeding global averages; however, workforce shortages are reported. Barriers to optimal kidney care include limited workforce capacity, lack of surveillance mechanisms, and suboptimal integration into national noncommunicable disease (NCD) strategies. Policy recognition of CKD as a health priority varies across countries. Although Western Europe exhibits strong kidney care infrastructure, opportunities for improvement exist, particularly in CKD prevention, surveillance, awareness, and policy implementation. Efforts to improve CKD care should include automated detection, educational support, and enhanced workflows. Based on these findings, health care professionals, stakeholders, and policymakers are called to act to enhance kidney care across the region.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Kidney Int Suppl (2011) Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Kidney Int Suppl (2011) Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido